Gene: HGH1
Official Full Name: HGH1 homologprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22817 | HGH1 Knockout cell line (HeLa) | Human | HGH1 | 1:3~1:6 | Negative | Online Inquiry |
KO22818 | HGH1 Knockout cell line (HCT 116) | Human | HGH1 | 1:2~1:4 | Negative | Online Inquiry |
KO22819 | HGH1 Knockout cell line (HEK293) | Human | HGH1 | 1:3~1:6 | Negative | Online Inquiry |
KO22820 | HGH1 Knockout cell line (A549) | Human | HGH1 | 1:3~1:4 | Negative | Online Inquiry |
HGH1 Gene Knockout Cell Lines are a specialized type of genetically modified cell lines that have been engineered to have specific deletions in the HGH1 gene, which encodes for the Human Growth Hormone (HGH). This product serves as a critical tool for researchers studying the biological roles and mechanisms of HGH in growth, metabolism, and various signaling pathways. The knockout approach allows scientists to assess the functional consequences of the absence of this hormone, providing insights into its impact on cellular behavior and potential pathological conditions related to growth disorders.
The key function of HGH1 Gene Knockout Cell Lines lies in their ability to facilitate the examination of the HGH signaling pathway. By eliminating the HGH gene, these cell lines enable the investigation of downstream effects on cellular growth, differentiation, and apoptosis. Researchers can utilize these models to dissect various biological processes that HGH is involved in, vastly improving our understanding of its roles in both physiology and disease.
Scientifically, HGH1 knockout cell lines hold substantial importance in biomedical research and clinical applications. They enable the study of growth hormone deficiencies and related conditions, such as Turner syndrome and Prader-Willi syndrome, thereby aiding in the development of targeted therapies and innovative treatment approaches. Furthermore, these cell lines can be employed in drug screening studies, allowing researchers to identify potential compounds that can modulate HGH activity or its downstream effects.
Compared to traditional cell lines that express the HGH gene, HGH1 Gene Knockout Cell Lines provide a unique advantage by offering a controlled environment to study the absence of HGH. Utilizing these knockout models allows for clearer attribution of observed effects specifically to HGH signaling, rather than confounding factors from its presence. This specificity streamlines the research process and increases the reliability of results.
For researchers and clinicians focused on endocrinology, metabolism, and associated disorders, HGH1 Gene Knockout Cell Lines present invaluable assets that promise to enhance the understanding of growth hormone function. The ability to rigorously explore the mechanistic details surrounding HGH opens avenues for therapeutic advancements and improved patient outcomes.
Our company strives to deliver high-quality biological products, backed by extensive expertise in genetic engineering and a commitment to fostering research and innovation in the life sciences. We ensure that our HGH1 Gene Knockout Cell Lines meet rigorous standards, empowering researchers with the tools necessary to advance scientific knowledge and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.